Literature DB >> 34315835

Clinical Profile and Outcome of COVID-19 Among Immunocompromised Children.

Sunil Kumar Rao1, Ashutosh Kumar2, Rajniti Prasad2, Vineeta Gupta2, Om Prakash Mishra2.   

Abstract

This retrospective study describes the clinical profile, risk of infection and outcome of coronavirus disease-19 in immuno-compromised children. It was found that children on immuno-suppressant medication has 2.89 times increased risk of infection (P=0.01). Disease manifestation was asymptomatic (P=0.01) or mild with predominant gastrointestinal symptoms (P=0.02) without alteration in immunosuppressive treatment regime.

Entities:  

Year:  2021        PMID： 34315835      PMCID： PMC8339160     

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


  9 in total

1.  Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis.

Authors:  Jitendra Meena; Jaivinder Yadav; Lokesh Saini; Arushi Yadav; Jogender Kumar
Journal:  Indian Pediatr       Date:  2020-06-24       Impact factor: 1.411

2.  Managing Children With Renal Diseases During the COVID-19 Pandemic.

Authors:  Anil Vasudevan; Mukta Mantan; Sriram Krishnamurthy; Priya Pais; Georgie Mathew; Pankaj Hari; Madhuri Kanitkar; Sanjeev Gulati; Arvind Bagga; Om P Mishra
Journal:  Indian Pediatr       Date:  2020-07-15       Impact factor: 1.411

3.  COVID-19 in children treated with immunosuppressive medication for kidney diseases.

Authors:  Matko Marlais; Tanja Wlodkowski; Samhar Al-Akash; Petr Ananin; Varun Kumar Bandi; Veronique Baudouin; Olivia Boyer; Luciola Vásquez; Sukanya Govindan; Nakysa Hooman; Iftikhar Ijaz; Reyner Loza; Marta Melgosa; Nivedita Pande; Lars Pape; Anshuman Saha; Dmitry Samsonov; Michiel F Schreuder; Jyoti Sharma; Sahar Siddiqui; Rajiv Sinha; Heather Stewart; Velibor Tasic; Burkhard Tönshoff; Katherine Twombley; Kiran Upadhyay; Marina Vivarelli; Donald J Weaver; Robert Woroniecki; Franz Schaefer; Kjell Tullus
Journal:  Arch Dis Child       Date:  2020-12-21       Impact factor: 3.791

4.  Clinical course of COVID-19 among immunocompromised children: a clinical case series.

Authors:  Huda El Dannan; Moza Al Hassani; Musaab Ramsi
Journal:  BMJ Case Rep       Date:  2020-10-31

5.  The severity of COVID-19 in children on immunosuppressive medication.

Authors:  Matko Marlais; Tanja Wlodkowski; Marina Vivarelli; Lars Pape; Burkhard Tönshoff; Franz Schaefer; Kjell Tullus
Journal:  Lancet Child Adolesc Health       Date:  2020-05-13

6.  COVID-19 associated with onset nephrotic syndrome in a pediatric patient: coincidence or related conditions?

Authors:  Amado Alvarado; Gabriela Franceschi; Evelin Resplandor; Jeannethe Sumba; Nelson Orta
Journal:  Pediatr Nephrol       Date:  2020-08-27       Impact factor: 3.714

7.  How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review.

Authors:  Chiara Minotti; Francesca Tirelli; Elisa Barbieri; Carlo Giaquinto; Daniele Donà
Journal:  J Infect       Date:  2020-04-23       Impact factor: 6.072

8.  Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment.

Authors:  Ondrej Hrusak; Tomas Kalina; Joshua Wolf; Adriana Balduzzi; Massimo Provenzi; Carmelo Rizzari; Susana Rives; María Del Pozo Carlavilla; Maria E V Alonso; Nerea Domínguez-Pinilla; Jean-Pierre Bourquin; Kjeld Schmiegelow; Andishe Attarbaschi; Pernilla Grillner; Karin Mellgren; Jutte van der Werff Ten Bosch; Rob Pieters; Triantafyllia Brozou; Arndt Borkhardt; Gabriele Escherich; Melchior Lauten; Martin Stanulla; Owen Smith; Allen E J Yeoh; Sarah Elitzur; Ajay Vora; Chi-Kong Li; Hany Ariffin; Alexandra Kolenova; Luciano Dallapozza; Roula Farah; Jelena Lazic; Atsushi Manabe; Jan Styczynski; Gabor Kovacs; Gabor Ottoffy; Maria S Felice; Barbara Buldini; Valentino Conter; Jan Stary; Martin Schrappe
Journal:  Eur J Cancer       Date:  2020-04-07       Impact factor: 9.162

9.  Relapse rate of nephrotic syndrome in the time of COVID-19.

Authors:  Jérôme Harambat; Lise Allard; Astrid Godron-Dubrasquet
Journal:  Pediatr Nephrol       Date:  2020-10-30       Impact factor: 3.714
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.